Combino Pharm (Malta) Ltd, Galenica Pharmaceutical Industry S.A., Glenmark Pharmaceuticals s.r.o., SVUS Pharma a.s.
PolandAll drugs from this manufacturer
-
The medicine is used to reduce the number of seizures in adults, adolescents, and children (from 2 or 4 years of age, depending on the type of epilepsy). It helps in the treatment of partial seizures and initially generalized tonic-clonic seizures.
Dosage form: tablets, film-coated
Active substance Dosage lacosamide 50 mg ATC: N03AX18
-
The medicinal product is used to reduce the number of seizures in adults, adolescents, and children (from 2 years of age) suffering from epilepsy with partial seizures. It may also be used in children from 4 years of age for the treatment of primarily generalized tonic-clonic seizures.
Dosage form: tablets, film-coated
Active substance Dosage lacosamide 100 mg ATC: N03AX18
-
The medicine is used to reduce the number of seizures in adults, adolescents, and children (from 2 or 4 years of age, depending on the type of epilepsy). It helps in the treatment of partial seizures and initially generalized tonic-clonic seizures.
Dosage form: tablets, film-coated
Active substance Dosage lacosamide 150 mg ATC: N03AX18
-
The medicine is used to reduce the number of seizures in adults, adolescents, and children (depending on the type of epilepsy). It helps in the treatment of partial seizures and initially generalized tonic-clonic seizures.
Dosage form: tablets, film-coated
Active substance Dosage lacosamide 200 mg ATC: N03AX18